Posterior reversible encephalopathy syndrome: About 2 cases related to the cyclosporine;Syndrome d'encéphalopathie postérieure réversible: À propos de 2 cas liés à la ciclosporine

Annales Francaises d'Anesthesie et de Reanimation

Volumn 22, Issue 5, 2003, Pages 466-469

  Lepoivre, T ^a   Treilhaud, M ^a   Auffray Calvier, E ^a   Rigal, J C ^a   Blanloeil, Y ^a  

^a CHU de Nantes   (France)

Author keywords

Cyclosporine; Neurotoxicity; Posterior reversible encephalopathy

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; GRAND MAL SEIZURE; HEADACHE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; VISUAL DISORDER;

EID: 0038825179     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(03)00097-2     Document Type: Article

References (12)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leuko-encephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339-46.
3. Gopal AK, Thorning DR, Back AL. Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings. Bone Marrow Transplant 1999;23:191-3.
4. Trullemans F, Grignard F, Van Camp B, Schots R. Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol 2001;67:94-9.
5. Bechstein O. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transplant Int 2000;13:313-26.
6. e Congrès national d'anesthésie et de réanimation. Paris: Elsevier; 1998. p. 649-63.
7. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leucoencephalopathy in organ transplant recipients. Transplantation 2000;69:467-72.
8. Goldstein AB, Goldstein LS, Perl MK, Haugh MT, Arroliga AC, Stillwell PC. Cystic fibrosis patients with and without central nervous system complications following lung transplantation. Pediatr Pulmonol 2000;30:203-6.
9. Rosencrantz R, Moon A, Raynes H, Spivak W. Cyclosporine-induced neurotoxicity during treatment of Crohn's disease: lack of correlation with previously reported risk factors. Am J Gastro-enterol 2001;96:2778-81.
10. Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. Am J Neuroradiol 1998;19:859-62.
11. Coley S, Porter D, Calamante F, Chong W, Connelly A. Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. Am J Neuroradiol 1999;20:1507-10.
12. Casey S, Sampaio R, Michel E, Truwit C. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 2000;21:1199-206.